Results 81 to 90 of about 5,690 (176)

Assessment of soluble ST2 as a biomarker for cardiac remodeling in heart failure patients [PDF]

Al-Azhar International Medical Journal
Background: Heart failure with reduced ejection fraction (HFrEF) continues to be a worldwide health burden, with ongoing adverse cardiac remodeling. Soluble suppression of tumorigenicity-2 (sST2) is a biomarker associated with myocardial inflammation and
Ahmed Gaafar, Ahmed Sedeek, Magdy Farouk, Yasser Sadek   +3 more
doaj   +1 more source

The elevated levels of soluble growth stimulation expressed gene 2 are associated with coronary atherosclerotic plaque destabilization in unstable angina patients: a case control study

BMC Cardiovascular Disorders
Background Plaque destabilization and rupture are the primary triggers of acute coronary syndrome (ACS). Soluble growth stimulation expressed gene 2 (sST2) has been implicated in cardiovascular disease.
Ning Li, Xinjian Li, Lin Ni, Xuewen Li
doaj   +1 more source

The diagnostic and prognostic value of soluble ST2 in Sepsis

Frontiers in Medicine
ObjectiveTo determine the diagnostic and prognostic value of soluble suppression of tumorigenicity 2 (sST2) in patients with sepsis.MethodsA total of 113 critically ill patients were enrolled at the emergency department of Beijing Chaoyang Hospital Jing ...
Xinghua Ye, Jia Wang, Le Hu, Ying Zhang, Yixuan Li, Jingchao Xuan, Silu Han, Yifan Qu, Long Yang, Jun Yang, Junyu Wang, Bing Wei   +11 more
doaj   +1 more source

The association between soluble ST2 and transplant-free survival in precapillary pulmonary hypertension

JHLT Open
Background: Soluble ST2 (sST2) is a decoy receptor for interleukin-33 and a prognostic biomarker in heart failure, but its utility in precapillary pulmonary hypertension (PH) is not well established.
Håvard Ravnestad, MD, PhD, Salaheldin Ahmed, MD, PhD, Charlotte M. Østby, RN, Einar Gude, MD, PhD, John-Peder Escobar Kvitting, MD, PhD, Kaspar Broch, MD, PhD, Annika E. Michelsen, PhD, Thor Ueland, Göran Rådegran, MD, PhD, Arne K. Andreassen, MD, PhD   +9 more
doaj   +1 more source

Diagnostic value of serum soluble suppression of tumorigenicity 2 in patients with heart failure in different types of heart diseases

Zhongguo linchuang yanjiu
Objective To observe the changes of soluble growth stimulation expression gene 2 (sST2) level in patients with heart failure in different types of heart diseases, and analyze the diagnostic value of sST2 in heart failure. Methods A total of 74 patients
XIA Li*, YIN Yi, ZHOU Dewei, WU Jiaming, WANG Hongzhi
doaj   +1 more source

Soluble suppression of tumorigenicity 2 associated with left ventricular thrombosis in patients with ST-segment elevation myocardial infarction

BMC Cardiovascular Disorders
Background Left ventricular thrombosis (LVT) after acute ST-segment elevation myocardial infarction (STEMI) is closely related to inflammation. Soluble Suppression of Tumorigenicity 2 (sST2) expressed as a novel inflammatory marker, has received much ...
Xinjia Du, Perkash Kumar, Chen Liu, Jiahua Liu, Lei Chen, Yuan Lu, Zhuoqi Zhang   +6 more
doaj   +1 more source

Association between sST2 Levels and Cardiovascular Outcomes and Effect of Sacubitril/Valsartan on sST2 Levels: Results From the PARADIGM-HF Trial [PDF]

Journal of Cardiac Failure, 2016
Eileen O'Meara, Margaret F. Prescott, Jean L. Rouleau, Lu-May Chiang, Scott D. Solomon, Karl Swedberg, Milton Packer, John J.V. McMurray, Michael R. Zile   +8 more
openaire   +1 more source

Prognostic value of soluble ST2 in cardiac magnetic resonance defined myocardial infarction with non-obstructive coronary arteries. [PDF]

Front Cardiovasc Med
Cui C, Liu D, Du M, Lu P, Yang Y, Chen L, Chen W, Zhang M.   +7 more
europepmc   +1 more source

Macroalbuminuria as a marker of cardiac damage in patients with type 2 diabetes: insights from multimodality cardiac imaging and biomarkers. [PDF]

J Physiol Biochem
Olloquiegui XI, Andueza SE, Izco MP, Salinas GLA, Lorente LF, Albéniz SR, Solis-Barquero SM, Aramendía-Vidaurreta V, Mora-Gutiérrez JM, Orbe J, Fernández-Seara MA, García-Fernández N.   +11 more
europepmc   +1 more source

Association Between Baseline Soluble ST2 Levels and Long-Term Outcomes After Percutaneous Coronary Intervention. [PDF]

Medicina (Kaunas)
Byeon J, Song YW, Roh KH, Kim KA, Kim S, Kim YR, Choi IJ.   +6 more
europepmc   +1 more source